Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGON: Peginterferon alfa-2b add-on to nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B
NCT01532843Phase 4Completed
- Sponsor
- Foundation for Liver Research
- Start
- Jun 2012
- Primary completion
- Aug 2015
- Countries
- 2
01
Overview
A Phase 4 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Foundation for Liver Research. Started Jun 2012; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01532843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532843.